Intrexon Corporation Organizes Around New Synthetic Biology Markets

GERMANTOWN, Md., May 9, 2013 /PRNewswire/ -- Intrexon Corporation, a leader in synthetic biology that is helping companies design and develop products incorporating its Better DNA, today announced it has aligned its industry markets to focus on four key sectors: Health, Food, Energy and Environment.

Intrexon currently has nine collaborations in Health and Food to create products embodying engineered bio-based solutions. The goal of the new market alignment is to accelerate business development across all of Intrexon's key market sectors using the company's Exclusive Channel Collaboration (ECC) model.

Since Intrexon's founding in 1998 the company has developed its core technology, the UltraVector® platform, to accelerate development of genetically-enhanced products at industrial scale. Using a dynamic library of more than two million diverse, modular genetic components, UltraVector enables the discovery, design, assembly and testing of a wide spectrum of multigenic biological systems.

As part of its new market strategy, Intrexon named the following executives with deep industry experience to lead each market sector:

• Health will be led by Dr. Samuel Broder, Executive Director of the Intrexon Institute for Biomolecular Research and former Director of the National Cancer Institute.
• Food will be led by Dr. Thomas Kasser, with more than twenty-five years of senior management experience in agricultural biotechnology and animal health and nutrition, recognized as a Monsanto Fellow for his scientific and technical excellence.
• Energy will be led by Robert Walsh, with over 30 years of global petroleum and chemical industry experience, including 26 years at Royal Dutch Shell.
• Environment will be led by Nick Macris, with 15 years in the specialty chemical, water treatment, agricultural chemical and biopesticide industries with many large and small companies including 3M, Rohm and Haas, and FMC Corporation

Chairman and Chief Executive Officer Randal J. Kirk said the new market alignment will help Intrexon achieve its vision to be one of the leading life science companies in the world.

"Our new sector organization, led by an outstanding team of industry veterans, will bring additional focus and rapidity to solving our partners' toughest synthetic biology problems," Kirk said. "It's a very exciting step toward empowering the bioindustrial revolution with solutions that enhance the quality and diversity of life."

About Intrexon Corporation

Intrexon Corporation is a privately held biotechnology company focused on collaborating with companies in Health, Food, Energy and the Environment to create bio-based products that improve the quality of life and the health of the planet. Through the company's proprietary UltraVector® platform, Intrexon provides its partners with industrial-scale design and development of multigenic biology. UltraVector delivers unprecedented control over the quality, reliability, and performance of living cells. We call it Better DNA and we invite you to discover more at www.dna.com.

Trademarks

Intrexon, UltraVector, mAbLogix and Better DNA are trademarks of Intrexon and/or its affiliates. Other names may be trademarks of their respective owners.

Safe Harbor Statement

Some of the statements made in this press release are forward-looking statements. These forward-looking statements are based upon our current expectations and projections about future events and generally relate to our plans, objectives and expectations for the development of our business. Although management believes that the plans and objectives reflected in or suggested by these forward-looking statements are reasonable, all forward-looking statements involve risks and uncertainties and actual future results may be materially different from the plans, objectives and expectations expressed in this press release.

For more information regarding Intrexon Corporation, contact:

SOURCE Intrexon Corporation